Notably, BD downregulated synaptic‐plasticity‐related proteins (Nogo‐A, NgR, RhoA, AGG, and CRMP2) in peri‐infarct brain tissue, suggesting that synaptic plasticity underpins the therapeutic efficacy of BD against PSS‐induced spasticity. This evidence concerns the gene RHOA and Behcet disease.